Skip to content

BPK-S Integration (Ceramic) Post Market Clinical Follow-Up

Prospektive, Klinische Studie Zur Marktbeobachtung (Post Market Follow-Up Study) Der Knieendoprothese BPK-S Integration Aus Keramikwerkstoff BIOLOX (R) Delta (Prospective Clinical Post Market Follow-up Study of the Total Knee Endoprosthesis BPK-S (Brehm Precision Knee System)Made of Ceramic Material BIOLOX (R) Delta

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03097471
Enrollment
40
Registered
2017-03-31
Start date
2011-05-31
Completion date
2018-03-31
Last updated
2017-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restoration if Knee Joint Function

Brief summary

Post-market prospective clinical study with a medical device. Data from patients that routinely receive a primary BPK-S-integration knee implant made of ceramic will be documented with a follow-up time of 2 years.

Interventions

DEVICEBPK-S Integration (Ceramic)

primary total knee endoprosthesis

Sponsors

Klemens Trieb
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Congenital or acquired knee joint defects/deformation which necessitate the implantation of a knee joint replacement * Defects or malfunctions of the knee joint * Degenerative, rheumatic, post-traumatic arthritis/arthrosis * Symptomatic knee instability * Reconstruction of flexibility * Patients with material hypersensitivity

Exclusion criteria

* Obesity or overweight of the patient * Acute or chronic infections near the implantation * Diseases that impair bone growth such as cancer, renal dialysis, osteopenia, etc. * Sensitivity to foreign matter in the implant materials * Bone tumors in the area of the implant anchoring * Illnesses which can be treated without using a knee implant * Lack of patient cooperation * Abuse of medication, drug abuse, alcoholism or mental disease * Pregnancy * Serious osteoporosis * Serious damage to the bone and soft tissue structures which impedes stable anchoring and joint function * Systemic diseases and metabolic disorders * Overload of the knee implant to be expected

Design outcomes

Primary

MeasureTime frame
Improvement of Knee Society Score12 months

Secondary

MeasureTime frame
Improvement of Knee Society Score over the course of the study3 months, 24 months
Improvement of EQ-5D (Euroquol 5 dimension) score3 month, 12 months, 24 months
Improvement of Oxford Score3 month, 12 months, 24 months
Documentation of Complications3 month, 12 months, 24 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026